Detalhe da pesquisa
1.
Preclinical human models and emerging therapeutics for advanced systemic mastocytosis.
Haematologica
; 103(11): 1760-1771, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-29976735
2.
The KIT and PDGFRA switch-control inhibitor DCC-2618 blocks growth and survival of multiple neoplastic cell types in advanced mastocytosis.
Haematologica
; 103(5): 799-809, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29439183
3.
A new human mast cell line expressing a functional IgE receptor converts to tumorigenic growth by KIT D816V transfection.
Blood
; 124(1): 111-20, 2014 Jul 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-24677542
4.
Co-operating STAT5 and AKT signaling pathways in chronic myeloid leukemia and mastocytosis: possible new targets of therapy.
Haematologica
; 99(3): 417-29, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24598853
5.
Th1-Polarized, Dengue Virus-Activated Human Mast Cells Induce Endothelial Transcriptional Activation and Permeability.
Viruses
; 12(12)2020 12 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33276578
6.
In vitro and in vivo efficacy of an anti-CD203c conjugated antibody (AGS-16C3F) in mouse models of advanced systemic mastocytosis.
Blood Adv
; 3(4): 633-643, 2019 02 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-30804017
7.
Tyrosine Kinase Inhibition in Mastocytosis: KIT and Beyond KIT.
Immunol Allergy Clin North Am
; 38(3): 527-543, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30007468
8.
A new humanized in vivo model of KIT D816V+ advanced systemic mastocytosis monitored using a secreted luciferase.
Oncotarget
; 7(50): 82985-83000, 2016 Dec 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-27783996
9.
Molecular defects in mastocytosis: KIT and beyond KIT.
Immunol Allergy Clin North Am
; 34(2): 239-62, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24745672